Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder

Review

(2190) Views  (529) Full article downloads

Authors: A Carlo Altamura, Jose M Goikolea

Published Date March 2008 Volume 2008:4(1) Pages 311 - 317

DOI: http://dx.doi.org/10.2147/NDT.S2703

A Carlo Altamura¹, Jose M Goikolea²

¹Department of Psychiatry, University of Milan, IRCCS Fondazione Ospedale Maggiore Policlinico Mangiagalli e Regina Elena, Milan, Italy; ²Bipolar Disorder Program, Hospital Clinic i Universitari, Barcelona, Spain

Abstract: Successful treatment of psychiatric disorders, including bipolar disorder and schizophrenia, is complicated and is affected by a broad range of factors associated with the diagnosis, choice of treatment and social factors. In these patients, treatment management must focus on accurate and early diagnosis, to ensure that correct treatment is administered as soon as possible. In both disorders, the treatment of the disease in the acute phase must be maintained long term to provide continuous relief and normal function; the treatment choice in the early stages of the disease may impact on long-term outcomes. In schizophrenia, treatment non-compliance is an important issue, with up to 50% of patients discontinuing treatment for reasons as diverse as efficacy failure, social barriers, and more commonly, adverse events. Treatment non-compliance also remains an issue in bipolar disorder, as tolerability of mood stabilizers, especially lithium, is not always good, and combination treatments are frequent. In order to achieve an optimal outcome in which the patient continues with their medication lifelong, treatment should be tailored to each individual, taking into account treatment and family history, and balancing efficacy with tolerability to maximize patient benefit and minimize the risk of discontinuation. These case studies illustrate how treatment should be monitored, tailored and often changed over time to meet these needs.

Keywords: bipolar disorder, recurrence, treatment management, schizophrenia, non-compliance, adverse events